Your browser doesn't support javascript.
loading
Glycemic Control in Simultaneous Islet-Kidney Versus Pancreas-Kidney Transplantation in Type 1 Diabetes: A Prospective 13-Year Follow-up.
Lehmann, Roger; Graziano, Jessica; Brockmann, Jens; Pfammatter, Thomas; Kron, Philipp; de Rougemont, Olivier; Mueller, Thomas; Zuellig, Richard A; Spinas, Giatgen A; Gerber, Philipp A.
Afiliação
  • Lehmann R; Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
  • Graziano J; Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
  • Brockmann J; Division of Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland.
  • Pfammatter T; Division of Radiology, University Hospital Zurich, Zurich, Switzerland.
  • Kron P; Division of Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland.
  • de Rougemont O; Division of Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland.
  • Mueller T; Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.
  • Zuellig RA; Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
  • Spinas GA; Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
  • Gerber PA; Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland philipp.gerber@usz.ch.
Diabetes Care ; 38(5): 752-9, 2015 May.
Article em En | MEDLINE | ID: mdl-25665814
OBJECTIVE: In patients with type 1 diabetes and end-stage renal disease, combined transplantation of a kidney together with a pancreas or isolated pancreatic islets are options to improve glycemic control. The aim of this study was to compare their long-term outcome with regard to metabolic control and surgical complication rate, as well as function of the transplanted kidney. RESEARCH DESIGN AND METHODS: We conducted a prospective cohort study in consecutive patients receiving either a pancreas or islet transplant simultaneously with or after kidney transplantation (simultaneous pancreas-kidney [SPK]/pancreas-after-kidney [PAK] or simultaneous islet-kidney [SIK]/islet-after-kidney [IAK] transplantation). RESULTS: Ninety-four patients who had undergone SPK/PAK transplantation were compared with 38 patients who had undergone SIK/IAK transplantation over a period of up to 13 years. HbA1c levels declined from 7.8 ± 1.3% (62 ± 14 mmol/mol) to 5.9 ± 1.1% (41 ± 12 mmol/mol), and from 8.0 ± 1.3% (64 ± 14 mmol/mol) to 6.5 ± 1.1% (48 ± 12 mmol/mol), respectively, in the SPK/PAK and SIK/IAK groups (P < 0.001 for both) and remained stable during follow-up, despite a reduction in the rate of severe hypoglycemia by >90%. The 5-year insulin independence rate was higher in the SPK/PAK group (73.6 vs. 9.3% in the SIK/IAK group), as was the rate of relaparotomy after transplantation (41.5 vs. 10.5% in the SIK/IAK group). There was no difference in the rate of kidney function decline. CONCLUSIONS: During a long-term follow-up, SPK/PAK transplantation as well as SIK/IAK transplantation resulted in a sustained improvement of glycemic control with a slightly higher glycated hemoglobin level in the SIK/IAK group. While insulin independence is more common in whole-organ pancreas recipients, islet transplantation can be conducted with a much lower surgical complication rate and no difference in kidney function decline.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Transplante das Ilhotas Pancreáticas / Transplante de Rim / Transplante de Pâncreas / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Transplante das Ilhotas Pancreáticas / Transplante de Rim / Transplante de Pâncreas / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2015 Tipo de documento: Article